DAFTAR PUSTAKA
1. Shaw JE, Sicree RA, Zimmet PZ. Diabetes Atlas : Global Estimates of the Prevalence of Diabetes for 2010 and 2030.
Diabetes Research and Clinical Practice .2010: 4-14
2. Zimmet P, Alberti KG, Shaw J. Global and Societal Implications of the Diabetes Epidemic.Nature.2001: 414: 782-7
3. Yngen M. Platelet Function in Diabetes Mellitus. Karolinska University Press, Stockholm, Sweden. 2005. 9-58
4. Yngen M. Platelet Hyperactivity in Diabetes Mellitus. European Cardiology. 2005:1-6
5. Wild S, Roglic G, Green A, et al. Global Prevalence of Diabetes : Estimates for the Year 2000 and Projections for 2030. Diabetes Care. Volume 27(5). 2004: 1047-53
6. Ministry of Health, Republic of Indonesia. Centre of Data and Information Indonesia Health Profile 2008. Jakarta; Ministry of Health Republic of Indonesia 2010
7. Pranoto A. Prediabetes dan Diabetes Melitus. Divisi Endokrin Metabolik. Bagian SMF Penyakit Dalam RSU Dr.Soetomo FK Unair, Surabaya.Indonesia
Proceeding Book 4th Endocrinology & Diabetes Forum of Sumatera Region Banda Aceh.USUPress . 2012: 123-5
9. Perkumpulan Endokrinologi Indonesia. Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. PB PERKENI. Jakarta. 2011 : 1-56.
10. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. Volume 33. Supplement 1. Januari 2010: S62-8
11. Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Diabetes Foundation. Clinical Diabetes. Volume 26(2). 2008: 77-82
12. Salman R. Diabetic Microvascular Complications: Prevention and Screening.Bahrain Medical Bulletin. Volume 26(2) .2004: 1-4 13. Takeuchi M, Takino J, Yamagishi S. Involvement of the Toxic
AGEs (TAGE)-RAGE system in the Pathogenesis of Diabetic Vascular Complications; A Novel Therapeutic Strategy. Current Drug Targets. Volume 11(11): 1468-82
15.Jindal S, Gupta S, Gupta R, et al. Platelet Indices in Diabetes Mellitus: Indicator of Diabetic Microvascular Complications.
Hematology. Vol 16(2).2011: 86-9
16.Bancroft AJ, Abel EW, Mclaren M, et al. Mean Platelet Volume is a Useful Parameter: a Reproducible Routine Method Using a Modified Coulter Thrombocytometer.Platelets. 11(7). 2000: 379-87
17.Bath PM, Butterworth RJ. Platelet Size : Measurement, Physiology and Vascular Disease. Blood Coagulation & Fibrinolysis. 7(2). 1996: 157-61
18.Hekimsoy Z, Payzin B, Ornek T, et al. Mean Platelet Volume in Type 2 Diabetic Patients. Journal of Diabetes and its Complications18. 2004. 173-6
19.Papanas N, Symeonidis G, Maltezos E, et al. Mean Platelet Volume in Patients with Type 2 Diabetes Mellitus. Platelets.
15(8). 2004: 475-8
20.Zuberi BF, Akhtar N, Afsar S. Comparison of Mean Platelet Volume in Patients with Diabetes Mellitus, Impaired Fasting Glucose and Non-Diabetic Subjects. Singapore Medical Journal. 49(2). 2008: 114-6
Mellitus. Journal of Diabetes and Its Cpmplications. 23. 2009: 89-94
22. Purnamasari D. Diagnosis dan Klasifikasi Diabetes Melitus. Dalam: Sudoyo AW dkk (eds). Buku Ajar Ilmu Penyakit Dalam. Jilid III. Edisi ke-5.InternaPublishing. Jakarta. 2009: 1880-3
23. Sugondo S. Diagnosis dan Klasifikasi Diabetes Melitus Terkini. Dalam: Penatalaksanaan Diabetes Melitus Terpadu. Balai Penerbit FKUI. Jakarta. 2005: 17-27
24.Powers AC. Diabetes Mellitus. In: Fauci AS, Braunwald E, Hauser SL, et al (eds). Harrison’s Principles of Internal Medicine. 17th edition. San Fransisco.McGraw-hill Companies. 2008: 2275-302 25. Tjokroprawiro A, Inlacin®, The Novel Insulin Sensitizer for Patients
with T2DM (Its Roles on Mono-and Add-on Therapy): Dalam Sucipto KW, Zufry H (eds). Proceeding Book, 4th Endocrinology & Diabetes Forum of Sumatera Region. Banda Aceh. USU Press. 2012: 62-7
27. Sugondo S. Diabetes Melitus sebagai Faktor Resiko Utama Penyakit Kardiovaskular. Yulherina (ed). Ikatan Dokter Indonesia.Jakarta. 2006: 1-45
28. Funk JL. Penyakit Pankreas Endokrin. Dalam: McPhee SJ, Ganong WF. Patofisiologi Penyakit : Pengantar Menuju Kedokteran Klinis. Edisi 5.EGC. 2011: 557-85
29. Situmorang TD. Perjalanan Klinik Penyakit Ginjal Diabetik. Dalam: Naskah Lengkap The 5th Jakarta Nephrology & Hypertension Course and Symposium on Hypertension.PERNEFRI. 2005:42-4
30. Henrika F. Pemeriksaan Protein Urin: Protein, Albumin/mikroalbumin, Protein Bence Jones, Hemoglobinuria dan Mioblobinuria. Dalam: Oesman F (ed). Pendidikan Berkesinambungan Patologi Klinik 2010. Departemen Patologi Klinik Fakultas Kedokteran Universitas Indonesia. Jakarta. 2010: 18-29
31. Hendromartono. Nefropati Diabetik. Dalam: Sudoyo AW dkk (eds) : Buku Ajar Ilmu Penyakit Dalam. Jilid III. Edisi ke-5.
InternaPublishing. Jakarta. 2009: 1942-6
33. Tobe SW, McFarlane PA, Naimark DM. Microalbuminuria in Diabetes Mellitus. Canadian Medical Association.167(5). 2002: 499-503
34. Immanuel S. Mikroalbuminuria: Update: Petanda Disfungsi Endotel. Dalam: Suryaatmadja M (ed). Pendidikan Berkesinambungan Patologi Klinik 2006. Departemen Patologi Klinik Fakultas Kedokteran Universitas Indonesia. Jakarta. Agustus 2006: 120-37 35. Anonymous. Cobas Integra 400/700/800. Albumin (Turbidimetric)
Urine and CSF Application.Roche.2005-03.V 6 EN:1-5
36. Fong DS, Aiello L, Gardner T, et al. Diabetic Retinopathy.
Diabetes Care.26 (suppl-1). 2003: s99-s102
37. Ozmen B, Guclu F, Kafesciler S, et al. The Relationship Between Glycosylated Haemoglobin and Diabetic Retinopathy in Patients Type 2 Diabetes.Turk Jem.11. 2007: 10-5
38. Pandelaki K. Retinopati Diabetik. Dalam: Sudoyo AW dkk (eds) : Buku Ajar Ilmu Penyakit Dalam. Jilid III. Edisi ke-5.
InternaPublishing.Jakarta. 2009: 1930-6
39. Subekti I. Neuropati Diabetik. Dalam: Sudoyo AW dkk (eds) : Buku Ajar Ilmu Penyakit Dalam. Jilid III. Edisi ke-5. InternaPublishing. Jakarta. 2009: 1947-51
41. Laffan M, Manning R. Investigation of Haemostasis. In : Lewis SM, Bain BJ, Bates I (eds). Dacie and Lewis Practical Haematology. 10thedition. Philadelphia :Churchill Livingstone. 2003 : 379-440. 42. Suharti C. Dasar-Dasar Hemostasis. Dalam : Sudoyo AW,
Setiyohadi B, Alwi I, dkk (eds). Buku Ajar Ilmu Penyakit Dalam. Edisi ke-4. Pusat Penerbitan Ilmu Penyakit Dalam FK UI. Jakarta. 2006: 749-754.
43. Oesman F, Setiabudy RD. Fisiologi Hemostasis dan Fibrinolisis. Dalam: Setiabudy RD. Hemostasis dan Trombosis. Edisi ke-3.
Balai Penerbit FKUI. Jakarta. 2007: 1-8.
44. Tambunan KL. Patogenesis Trombosis. Dalam : Sudoyo AW, Setiyohadi B, Alwi I, dkk (eds). Buku Ajar Ilmu Penyakit Dalam. Edisi ke-4. Pusat Penerbitan Ilmu Penyakit Dalam FK UI. Jakarta; 2006 : 755-758.
45. Miller JL, Rao K. Blood Platelets and Von Willebrand Disease. In: McPherson RA, Pincus MR (eds). Henry`s Clinical Diagnosis and Management by Laboratory Methods, 21st edition. USA:Elsevier. 2007: 747-754
47. Calverley DC, Maness LJ. Platelet Function in Hemostasis and Thrombosis. In : Greer JP, Foerster J, Lukens JN, et al (eds). Wintrobe`s Clinical Hematology. 11th edition. Lippincott Williams and Wilkins. USA. 2004 : 651-669.
48. Brass LF, Stalker TJ. Mechanism of Platelet Activation. In : Gresele P, Fuster V, Page JA. Et al (eds). Platelets in Hematologic and Cardiovascular Disorders. Cambridge University Press. UK. 2008: 37-48.
49. Setiabudy RD. Pemantauan Obat Anti Trombosit. Dalam: Pendidikan Berkesinambungan Patologi Klinik. Bagian Patologi Klinik FK UI. Jakarta. 2004: 121-133.
50. Ferreiro JL, Gomez JA, Angiolillo DJ. Platelet Abnormalities in Diabetes Mellitus. Diabetes & Vascular Disease Research. 7(4). 2010: 251-9
51. Vinik AI, Erbas T, Nolan R, et al.Platelet Dysfunction in Diabetes Mellitus.Diabetes Care. Volume 24(8). Agustus 2001:1476-85 52. Schneider DJ. Factors Contributing to Increased Platelet
Reactivity in People with Diabetes.Diabetes Care. Volume 32(4). April 2009: 525-7
54. Anonymous. Sysmex XT-2000i/XT-1800i. Introduction for Use. Quality Control
55. Pagana KD, Pagana TJ. Platelet Volume, Mean (Mean Platelet Volume/MPV). In:Mosby’s Manual of Diagnostic and Laboratory Tests. 3rdedition.Mosby Elsevier.2006:412-4
56. Kodiatte TA, Manikyam UK, Rao SB. Mean Platelet Volume in Type 2 Diabetes Mellitus.Journal of Laboratory Physicians. Vol 4. Jan-Jun 2012: 5-9
57. Halushka PV,Lurie D & Colwell JA. Increased Synthesis of Prostaglandin-E-like Material by Platelets from Patients with Diabetes Mellitus. New England Journal of Medicine.1977;297:1306-10
58. Wahyuni AS. Statistika Kedokteran (Disertai aplikasi dengan SPSS)
59. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guidelines. Diabetic Retinopathy. San Francisco, CA. American Academy of Ophthalmology.2008 (4th Printing 2012). Available at : www.aao.org/ppp. (Access on November,2012)
60. Anonymous. Cobas Integra 400/700/800. Creatinine plus ver.2
62. Anonymous. Albumin Urine/CSF Package Insert Calibrator.
Cobas. Roche/Hitachi analyzers. p 1-4
63. Anonymous. Precinorm PUC Package Insert Control. Cobas. Roche/Hitachi analyzers. p 1
64. Anonymous. Creatinine Package Insert Calibrator. Cobas. Integra 400/800 analyzers. p 14
65. Anonymous. Precinorm U Package Insert Control. Cobas. Integra 400/800 analyzers. p 17
66. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean Platelet Volume in Patients with Metabolic Syndrome and its Relationship with Coronary Artery Disease. Thromb Res
2007;120:245–50.
67. Martyn CN, Matthews DM, Popp-Snijders, Tucker J, et al. Effects of Sorbinil Treatment on Erythrocytes and Platelets of Persons with Diabetes. Diabetes Care, Vol. 9. 1. Januari-Februari. 1986:36-9
68. Karpen CW, Pritchard KA, Merola AJ, et al. Alterations of the Prostacyclin-Thromboxane Ratio in Streptozotocin Induced Diabetic Rats.Prostaglandins Leukotrienes Med. 1982; 8:93-103. 69.Aydınlı S, Saydam G, Şahin F, et al. The Relationship between
Mean Platelet Volume, In-vitro Platelet Function Tests and
